532482 Stock Overview
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Granules India Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹410.90 |
| 52 Week High | ₹480.50 |
| 52 Week Low | ₹272.00 |
| Beta | 0.29 |
| 1 Month Change | -0.54% |
| 3 Month Change | -1.40% |
| 1 Year Change | 36.74% |
| 3 Year Change | 24.70% |
| 5 Year Change | 261.87% |
| Change since IPO | 13,372.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532482 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -2.6% | -2.5% | -2.5% |
| 1Y | 36.7% | 55.2% | 44.5% |
Return vs Industry: 532482 underperformed the Indian Pharmaceuticals industry which returned 55.2% over the past year.
Return vs Market: 532482 underperformed the Indian Market which returned 44.5% over the past year.
Price Volatility
| 532482 volatility | |
|---|---|
| 532482 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 532482 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532482's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 3,650 | Krishna Chigurupati | www.granulesindia.com |
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology.
Granules India Limited Fundamentals Summary
| 532482 fundamental statistics | |
|---|---|
| Market cap | ₹100.69b |
| Earnings (TTM) | ₹3.95b |
| Revenue (TTM) | ₹45.26b |
25.2x
P/E Ratio2.2x
P/S RatioIs 532482 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532482 income statement (TTM) | |
|---|---|
| Revenue | ₹45.26b |
| Cost of Revenue | ₹22.60b |
| Gross Profit | ₹22.66b |
| Other Expenses | ₹18.71b |
| Earnings | ₹3.95b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.31 |
| Gross Margin | 50.06% |
| Net Profit Margin | 8.73% |
| Debt/Equity Ratio | 46.5% |
How did 532482 perform over the long term?
See historical performance and comparison